NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner
Throughout its history, NCCS has advocated for an efficient cancer drug review process that considers the needs of cancer patients while ensuring that products approved by the FDA are safe and effective and will help patients survive longer and live well with cancer.
“As a physician and cancer survivor, Dr. Gottlieb understands the human toll cancer takes on individuals and families, during both treatment and long-term survivorship,” said Shelley Fuld Nasso, NCCS Chief Executive Officer. “He is open to a wide range of perspectives, including those of the patients whose lives depend on a strong FDA. We look forward to working with him as a partner at the FDA to ensure cancer patients have access to safe and effective treatments.”
Dr. Gottlieb is an NCCS Cancer Policy Advisor, has collaborated with NCCS to host a policy discussion on strategies to put patients first in payment reform efforts, and has been a frequent presenter at NCCS Cancer Policy Roundtable meetings.
About the National Coalition for Cancer Survivorship
Founded by and for cancer survivors in 1986, the National Coalition for Cancer Survivorship advocates to transform the cancer care system for all touched by cancer, from the moment of diagnosis. A voice for cancer survivors and their families in Washington, DC, NCCS’ vision is cancer care that supports survivors and their families, that is affordable and accessible, and that considers individuals’ goals and values.